- Home
- STRO vs GHG Comparison
STRO vs GHG Comparison
Compare STRO & GHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- GHG
- Stock Information
- Founded
- STRO 2003
- GHG 2004
- Country
- STRO United States
- GHG China
- Employees
- STRO N/A
- GHG N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- GHG Hotels/Resorts
- Sector
- STRO Health Care
- GHG Consumer Discretionary
- Exchange
- STRO Nasdaq
- GHG Nasdaq
- Market Cap
- STRO 292.6M
- GHG 289.4M
- IPO Year
- STRO 2018
- GHG 2018
- Fundamental
- Price
- STRO $2.76
- GHG $2.72
- Analyst Decision
- STRO Strong Buy
- GHG
- Analyst Count
- STRO 7
- GHG 0
- Target Price
- STRO $12.14
- GHG N/A
- AVG Volume (30 Days)
- STRO 863.7K
- GHG 5.1K
- Earning Date
- STRO 11-13-2024
- GHG 11-21-2024
- Dividend Yield
- STRO N/A
- GHG 3.70%
- EPS Growth
- STRO N/A
- GHG N/A
- EPS
- STRO N/A
- GHG 0.28
- Revenue
- STRO $160,955,000.00
- GHG $201,166,731.00
- Revenue This Year
- STRO N/A
- GHG N/A
- Revenue Next Year
- STRO N/A
- GHG $8.78
- P/E Ratio
- STRO N/A
- GHG $9.94
- Revenue Growth
- STRO 230.90
- GHG N/A
- 52 Week Low
- STRO $2.45
- GHG $2.31
- 52 Week High
- STRO $6.13
- GHG $4.10
- Technical
- Relative Strength Index (RSI)
- STRO 37.80
- GHG 46.87
- Support Level
- STRO $2.55
- GHG $2.66
- Resistance Level
- STRO $2.76
- GHG $2.76
- Average True Range (ATR)
- STRO 0.26
- GHG 0.09
- MACD
- STRO -0.03
- GHG 0.01
- Stochastic Oscillator
- STRO 17.22
- GHG 48.98
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.